Approval · Notice of Compliance 8974 · 2007
ALVESCO: Notice of Compliance 8974
Issued August 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8974
- Date
- August 14, 2007
- Company
- Nycomed Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Corticosteroid for oral inhalation
Products in this notice
Medicinal ingredients
- CICLESONIDE 50 MCG per ACT
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT